Maria Christina Herrera, MD, MSHP
Assistant ProfessorAbout
Research
Publications
2026
Naloxone Access in Schools: A National Survey of School Nurses in the United States
Calihan J, Herrera M, Jinks-Chang S, Wilson J, McDonald C, Dowshen N, Bobrowski C, Edelman E, Bagley S. Naloxone Access in Schools: A National Survey of School Nurses in the United States. Substance Use Research And Treatment 2026, 20: 29768357261478395. PMID: 42630626, PMCID: PMC13494342, DOI: 10.1177/29768357261478395.Peer-Reviewed Original ResearchThis study shows that while 90% of U.S. schools stock naloxone (an opioid overdose reversal medication), most restrict access and rarely train students to use it.
2025
Physician Experiences of Substance Use Disorder Management in Pediatric Hospitals: A Qualitative Study of Key Informant Interviews
Kronish A, MacFarlane Z, Miller V, Herrera M. Physician Experiences of Substance Use Disorder Management in Pediatric Hospitals: A Qualitative Study of Key Informant Interviews. Journal Of Adolescent Health 2025, 77: 1108-1114. PMID: 40996381, PMCID: PMC13281965, DOI: 10.1016/j.jadohealth.2025.08.017.Peer-Reviewed Original ResearchCharacterization of a Young Adult Sample Accessing Buprenorphine Via Telehealth in Philadelphia, PA
Herrera M, Lazariu V, O’Donnell N, Gehri G, Rohacs N, Barnes J, Wilson J, Perrone J, Lowenstein M. Characterization of a Young Adult Sample Accessing Buprenorphine Via Telehealth in Philadelphia, PA. Journal Of Addiction Medicine 2025, 20: 109-112. PMID: 41656552, DOI: 10.1097/adm.0000000000001495.Peer-Reviewed Original ResearchPediatrician Perspectives on Incorporating Discussion of Police Encounters Into Anticipatory Guidance for Black Youth and Their Caregivers
Eugene J, Nelson M, Neergaard R, Edmondson E, Capponi S, Herrera M, Shea J, Yun K, Jaffe N, Premo J, Dalembert G. Pediatrician Perspectives on Incorporating Discussion of Police Encounters Into Anticipatory Guidance for Black Youth and Their Caregivers. JAMA Pediatrics 2025, 179: 350-352. PMID: 39804654, PMCID: PMC11877170, DOI: 10.1001/jamapediatrics.2024.6167.Peer-Reviewed Original Research
2024
Opportunities to enhance retention on medication for opioid use disorder for adolescents and young adults: results from a qualitative study with medical providers in Philadelphia, PA
Herrera M, Darien K, Wood S, Hadland S, Deanna Wilson J, Dowshen N. Opportunities to enhance retention on medication for opioid use disorder for adolescents and young adults: results from a qualitative study with medical providers in Philadelphia, PA. Harm Reduction Journal 2024, 21: 210. PMID: 39581981, PMCID: PMC11587537, DOI: 10.1186/s12954-024-01113-8.Peer-Reviewed Original ResearchFacilitators and Barriers to Implementing HIV Testing and Pre-Exposure Prophylaxis in Substance Use Treatment Programs: Perspectives of Non-medical Staff
Herrera M, Mahajan A, Bonett S, Aronowitz S, Bauermeister J, da Silva D. Facilitators and Barriers to Implementing HIV Testing and Pre-Exposure Prophylaxis in Substance Use Treatment Programs: Perspectives of Non-medical Staff. Substance Use & Addiction Journal 2024, 45: 548-558. PMID: 39234640, PMCID: PMC11970037, DOI: 10.1177/29767342241274077.Peer-Reviewed Original ResearchCo-delivery of HIV pre-exposure prophylaxis (PrEP) and HIV testing among publicly insured adolescents and young adults (AYA) receiving medication for opioid use disorder (MOUD)
Herrera M, Johnson J, Lim S, Morales K, Wilson J, Hadland S, Metzger D, Wood S, Dowshen N. Co-delivery of HIV pre-exposure prophylaxis (PrEP) and HIV testing among publicly insured adolescents and young adults (AYA) receiving medication for opioid use disorder (MOUD). Drug And Alcohol Dependence 2024, 257: 111132. PMID: 38387256, PMCID: PMC11031309, DOI: 10.1016/j.drugalcdep.2024.111132.Peer-Reviewed Original Research
2023
A Qualitative Study of Barriers and Facilitators to Integrating Medications for Opioid Use Disorder and HIV Preexposure Prophylaxis for Adolescents and Young Adults
Herrera M, Darien K, Wood S, Hadland S, Metzger D, Dowshen N. A Qualitative Study of Barriers and Facilitators to Integrating Medications for Opioid Use Disorder and HIV Preexposure Prophylaxis for Adolescents and Young Adults. Journal Of Addiction Medicine 2023, 17: e349-e354. PMID: 37934522, PMCID: PMC10740380, DOI: 10.1097/adm.0000000000001195.Peer-Reviewed Original Research
2020
Using Provider Incentives and an Opt-Out Strategy in a Successful Quality Initiative to Increase Chlamydia Screening
Elattma A, Laves E, Taber B, Karvonen K, Herrera M, Bakken E. Using Provider Incentives and an Opt-Out Strategy in a Successful Quality Initiative to Increase Chlamydia Screening. The Joint Commission Journal On Quality And Patient Safety 2020, 46: 326-334. PMID: 32386995, DOI: 10.1016/j.jcjq.2020.03.003.Peer-Reviewed Original Research
Clinical Care
Overview
Maria Christina Herrera, MD, is a pediatrician specializing in adolescent medicine. She focuses on caring for adolescents and young adults, addressing conditions related to general health, substance use, and preventive care, including HIV prevention. Dr. Herrera works to enhance access to essential health services for marginalized youth.
As an assistant professor of pediatrics at Yale School of Medicine, Dr. Herrera conducts research on the intersection of HIV and substance use among adolescents, aiming to improve prevention strategies and healthcare access.
Dr. Herrera completed her medical degree at Columbia University and a graduate degree at the University of Pennsylvania. She completed her residency at the University of California San Francisco Medical Center and a fellowship in adolescent medicine at the Children’s Hospital of Pennsylvania.
Clinical Specialties
News
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.